June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
The Value of Routine Preoperative Medical Testing Before Vitreoretinal Surgery
Author Affiliations & Notes
  • Ajay Shalwala
    Vanderbilt Eye Institute, Nashville, TN
  • Richard Hwang
    Vanderbilt Eye Institute, Nashville, TN
  • Ariana Tabing
    Vanderbilt University School of Medicine, Nashville, TN
  • Stephen Kim
    Vanderbilt Eye Institute, Nashville, TN
  • Footnotes
    Commercial Relationships Ajay Shalwala, None; Richard Hwang, None; Ariana Tabing, None; Stephen Kim, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2148. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ajay Shalwala, Richard Hwang, Ariana Tabing, Stephen Kim; The Value of Routine Preoperative Medical Testing Before Vitreoretinal Surgery. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2148.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Screening medical tests are performed on patients in preparation for vitreoretinal surgery, but the benefit of routine testing is uncertain. This study aims to determine the predictive value of routine medical testing for post-operative systemic adverse events.

Methods: Medical charts of 2103 patients aged 17 or greater who underwent vitreoretinal surgery between January 2002 and November 2011 at Vanderbilt University in Nashville, Tennessee were reviewed for baseline comorbidities, pre-operative testing, and adverse events occurring at the time of or within 30 days of surgery. Charts were excluded if there were less than 7 days of documented follow-up. Logistic regression analysis was performed to correlate adverse events with pre-operative testing and baseline comorbidities.

Results: Of 2033 included patients, 83 experienced adverse events, with 9 patients having multiple events. Of 95 total adverse events observed, 66 (69%) occurred in the first 24 hours post-operatively, while the remaining 29 (31%) occurred between post-operative days 1 and 30. The most common adverse events were bradycardia (22 events) and desaturation (19 events). Presence of coronary artery disease, chronic renal failure, chronic liver disease, and history of cerebrovascular accident all independently predicted adverse events (p < 0.05), while age, race, diabetes, COPD, smoking history, asthma, and systemic malignancy were not associated. Pre-operative renal function testing (blood urea nitrogen and creatinine) appeared to reduce the risk of adverse events (p < 0.05) while general anesthesia increased the risk compared to local anesthesia (p < 0.001).

Conclusions: The incidence of adverse events following vitreoretinal surgery in this series was 4.1%. General anesthesia and the presence of specific comorbidities increased the risk of adverse events while pre-operative renal function testing appeared to be protective. This information may allow more selective testing for those individuals at greatest risk for adverse systemic events after vitreoretinal surgery and consequently reduce the burden of routine testing in those individuals at low risk.

Keywords: 762 vitreoretinal surgery • 462 clinical (human) or epidemiologic studies: outcomes/complications • 464 clinical (human) or epidemiologic studies: risk factor assessment  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.